featured
Myeloprotection With Trilaciclib in Chinese Patients With Extensive-Stage SCLC Receiving Chemotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Lung Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Myeloprotection with trilaciclib in Chinese patients with extensive-stage small cell lung cancer receiving chemotherapy: Results from a randomized, double-blind, placebo-controlled phase III study (TRACES)
Lung Cancer 2024 Feb 01;188(xx)107455, Y Cheng, L Wu, D Huang, Q Wang, Y Fan, X Zhang, H Fan, W Yao, B Liu, G Yu, Y Pan, F Xu, Z He, X Dong, R Ma, X Min, X Ge, H Chen, Q Liu, Y Hu, Y Liu, C Yang, Y Yang, X Li, L ZhouFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.